pfizer glp-1 drug 2 Companies Poised to Capitalize on the Rise of Weight Loss Drugs Understanding GLP-1 Drugs: Cost, Safety,

Introduction The global obesity market is entering a new phase

Somehow, its becoming even harder to get a GLP-1.

A newly published clinical investigation in the British Journal of Anaesthesia (May 2025 issue) reveals compelling evidence linking glucagon-like peptide-1 receptor agonists (GLP-1RAs) to impaired gastric emptying (IGE)

Learn how GLP-1 receptor agonists help patients with type 2 diabetes and obesity manage blood sugar, lose weight, and protect heart health.

Upper respiratory tract infections (URTIs) were the most frequently reported adverse event (8 of 12 reporting studies, 66.7%), occurring at rates comparable to controls across RCTs (GRADE: MODERATE certainty)

FDA-approved semaglutide products (Ozempic, Wegovy, Rybelsus) are commercially available